Health-Chem Corporation
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts researc… Read more
Health-Chem Corporation (HCLC) - Total Assets
Latest total assets as of June 2007: $5.54 Million USD
Based on the latest financial reports, Health-Chem Corporation (HCLC) holds total assets worth $5.54 Million USD as of June 2007.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Health-Chem Corporation - Total Assets Trend (1985–2006)
This chart illustrates how Health-Chem Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Health-Chem Corporation - Asset Composition Analysis
Current Asset Composition (December 2006)
Health-Chem Corporation's total assets of $5.54 Million consist of 70.1% current assets and 29.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.8% |
| Accounts Receivable | $1.89 Million | 32.5% |
| Inventory | $937.00K | 16.2% |
| Property, Plant & Equipment | $1.53 Million | 26.4% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1985–2006)
This chart illustrates how Health-Chem Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Health-Chem Corporation's current assets represent 70.1% of total assets in 2006, an increase from 64.7% in 1985.
- Cash Position: Cash and equivalents constituted 19.8% of total assets in 2006, down from 40.2% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 1985.
- Asset Diversification: The largest asset category is accounts receivable at 32.5% of total assets.
Health-Chem Corporation Competitors by Total Assets
Key competitors of Health-Chem Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Health-Chem Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Health-Chem Corporation generates 1.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Health-Chem Corporation is currently not profitable relative to its asset base.
Health-Chem Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.20 | 1.92 | 1.84 |
| Quick Ratio | 0.16 | 0.92 | 0.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-15.78 Million | $ 7.00 Million | $ 7.70 Million |
Health-Chem Corporation - Advanced Valuation Insights
This section examines the relationship between Health-Chem Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -16.8% |
| Total Assets | $5.79 Million |
| Market Capitalization | $0.99 USD |
Valuation Analysis
Below Book Valuation: The market values Health-Chem Corporation's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Health-Chem Corporation's assets decreased by 16.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Health-Chem Corporation (1985–2006)
The table below shows the annual total assets of Health-Chem Corporation from 1985 to 2006.
| Year | Total Assets | Change |
|---|---|---|
| 2006-12-31 | $5.79 Million | -16.84% |
| 2005-12-31 | $6.97 Million | -6.41% |
| 2004-12-31 | $7.44 Million | +52.21% |
| 2003-12-31 | $4.89 Million | -83.65% |
| 1997-12-31 | $29.90 Million | -7.72% |
| 1996-12-31 | $32.40 Million | -3.86% |
| 1995-12-31 | $33.70 Million | +4.66% |
| 1994-12-31 | $32.20 Million | +10.27% |
| 1993-12-31 | $29.20 Million | +1.04% |
| 1992-12-31 | $28.90 Million | -26.09% |
| 1991-12-31 | $39.10 Million | -9.91% |
| 1990-12-31 | $43.40 Million | -26.81% |
| 1989-12-31 | $59.30 Million | +3.31% |
| 1988-12-31 | $57.40 Million | -7.57% |
| 1987-12-31 | $62.10 Million | -7.45% |
| 1986-12-31 | $67.10 Million | +3.39% |
| 1985-12-31 | $64.90 Million | -- |